Stephanie L Smith1, David J Grelotti2, Reginald Fils-Aime3, Eugenie Uwimana4, Jean-Sauveur Ndikubwimana4, Tatiana Therosme3, Jennifer Severe3, Dominique Dushimiyimana4, Clemence Uwamariya4, Robert Bienvenu4, Yoldie Alcindor3, Eddy Eustache3, Giuseppe J Raviola5, Gregory L Fricchione6. 1. Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA, USA 02115; Partners In Health, 888 Commonwealth Avenue, 3rd Floor, Boston, MA USA 02215; Division of Medical Psychiatry, Brigham and Women's Hospital, 75 Francis Street, Boston, MA USA 02115. Electronic address: Stephanie_Smith@hms.harvard.edu. 2. Partners In Health, 888 Commonwealth Avenue, 3rd Floor, Boston, MA USA 02215; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA, USA 02115. 3. Department of Mental Health and Psychosocial Services, Zanmi Lasante, Haiti. 4. Butaro Hospital, Ministry of Health, Burera District, Rwanda. 5. Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA, USA 02115; Partners In Health, 888 Commonwealth Avenue, 3rd Floor, Boston, MA USA 02215. 6. Division of Psychiatry and Medicine, Pierce Division of Global Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Boston, MA USA 02114.
Abstract
OBJECTIVE: The catatonic syndrome ("catatonia") is characterized by motor and motivation dysregulation and is associated with a number of neuropsychiatric and medical disorders. It is recognizable in a variety of clinical settings. We present observations from the treatment of four individuals with catatonia in Haiti and Rwanda and introduce a treatment protocol for use in resource-limited settings. METHODS: Four patients from rural Haiti and Rwanda with clinical signs of catatonia and a positive screen using the Bush-Francis Catatonia Rating Scale were treated collaboratively by general physicians and mental health clinicians with either lorazepam or diazepam. Success in treatment was clinically assessed by complete remittance of catatonia symptoms. RESULTS: The four patients in this report exhibited a range of characteristic and recognizable signs of catatonia, including immobility/stupor, stereotypic movements, echophenomena, posturing, odd mannerisms, mutism and refusal to eat or drink. All four cases presented initially to rural outpatient general health services in resource-limited settings. In some cases, diagnostic uncertainty initially led to treatment with typical antipsychotics. In each case, proper identification and treatment of catatonia with benzodiazepines led to significant clinical improvement. CONCLUSION: Catatonia can be effectively and inexpensively treated in resource-limited settings. Identification and management of catatonia are critical for the health and safety of patients with this syndrome. Familiarity with the clinical features of catatonia is essential for health professionals working in any setting. To facilitate early recognition of this treatable disorder, catatonia should feature more prominently in global mental health discourse.
OBJECTIVE: The catatonic syndrome ("catatonia") is characterized by motor and motivation dysregulation and is associated with a number of neuropsychiatric and medical disorders. It is recognizable in a variety of clinical settings. We present observations from the treatment of four individuals with catatonia in Haiti and Rwanda and introduce a treatment protocol for use in resource-limited settings. METHODS: Four patients from rural Haiti and Rwanda with clinical signs of catatonia and a positive screen using the Bush-Francis Catatonia Rating Scale were treated collaboratively by general physicians and mental health clinicians with either lorazepam or diazepam. Success in treatment was clinically assessed by complete remittance of catatonia symptoms. RESULTS: The four patients in this report exhibited a range of characteristic and recognizable signs of catatonia, including immobility/stupor, stereotypic movements, echophenomena, posturing, odd mannerisms, mutism and refusal to eat or drink. All four cases presented initially to rural outpatient general health services in resource-limited settings. In some cases, diagnostic uncertainty initially led to treatment with typical antipsychotics. In each case, proper identification and treatment of catatonia with benzodiazepines led to significant clinical improvement. CONCLUSION:Catatonia can be effectively and inexpensively treated in resource-limited settings. Identification and management of catatonia are critical for the health and safety of patients with this syndrome. Familiarity with the clinical features of catatonia is essential for health professionals working in any setting. To facilitate early recognition of this treatable disorder, catatonia should feature more prominently in global mental health discourse.
Authors: F M M A van der Heijden; S Tuinier; N J M Arts; M L C Hoogendoorn; R S Kahn; W M A Verhoeven Journal: Psychopathology Date: 2005-02-15 Impact factor: 1.944
Authors: Pamela Y Collins; Vikram Patel; Sarah S Joestl; Dana March; Thomas R Insel; Abdallah S Daar; Warwick Anderson; Muhammad A Dhansay; Anthony Phillips; Susan Shurin; Mark Walport; Wendy Ewart; Sir John Savill; Isabel A Bordin; E Jane Costello; Maureen Durkin; Christopher Fairburn; Roger I Glass; Wayne Hall; Yueqin Huang; Steven E Hyman; Kay Jamison; Sylvia Kaaya; Shitij Kapur; Arthur Kleinman; Adesola Ogunniyi; Angel Otero-Ojeda; Mu-Ming Poo; Vijayalakshmi Ravindranath; Barbara J Sahakian; Shekhar Saxena; Peter A Singer; Dan J Stein Journal: Nature Date: 2011-07-06 Impact factor: 49.962
Authors: David J Grelotti; Amy C Lee; Joseph Reginald Fils-Aimé; Jacques Solon Jean; Tatiana Therosmé; Handy Petit-Homme; Catherine M Oswald; Giuseppe Raviola; Eddy Eustache Journal: Ann Glob Health Date: 2015 Sep-Oct Impact factor: 2.462